Allscripts

Allscripts
Healthcare Solutions, Inc.
Public
Traded as NASDAQ: MDRX
S&P 400 Component
Industry Information Technology
Founded 1982 (as Medic Computer Systems)
1986 (as Allscripts)
Headquarters Chicago, Illinois
Key people
Paul M. Black (CEO)
Products [1]Analytics and Insights
[2]Care Coordination
[3]Clinical
[4]Financial
[5]Patient Engagement
Revenue Increase US$1.81 Billion (FY 2017) [6]
Increase US$59.8 Million (FY 2016) [6]
Decrease US$-25.7 Million (FY 2016) [6]
Total assets Increase US$3.832 Billion (FY 2016) [6]
Total equity Decrease US$1.232 Billion (FY 2016') [6]
Number of employees
7,500 (2016)[6]
Website allscripts.com

Allscripts Healthcare Solutions, Inc. (MDRX-NASDAQ) is a publicly traded American company that provides physician practices, hospitals, and other healthcare providers with practice management and electronic health record technology. Allscripts also provides solutions for patient engagement and care coordination, as well as financial and analytics technology. The company has more than 180,000 physician users and has solutions in 2,700 hospitals and 13,000 extended care organizations.[7]

Allscripts was founded in 1986 and is headquartered in Chicago, Illinois. An additional key operations office is located in Raleigh, North Carolina.[8]

In 2008, Allscripts merged with the healthcare systems operations of rival, Misys.[9] In 2010, Allscripts-Misys merged with another major healthcare information technology competitor, Eclipsys. In March 2013, Allscripts acquired dbMotion, Ltd., a supplier of community health solutions and Jardogs LLC, a patient engagement solution provider, both privately held.[10]

MyWay Complications

In October 2012, Allscripts announced plans to discontinue their small practice software, MyWay. The solution fell short of meeting federal requirements for EHR incentives and some practices experienced issues after implementing the software. Allscripts offered a free upgrade to their Professional Suites platform as well as training for the new platform.[11][12]

In December 2012, four physician practices brought about a class-action suit against Allscripts due to selling the "buggy" MyWay EHR and later discontinuing it. It is believed to be a first-of-its-kind case. The parties reached a joint settlement agreement that received final approval from the trial court judge.[13][14] With this first lawsuit of this nature it has become a reference for future cases in this industry.[15]

Eclipsys Merger

Allscripts and Eclipsys merged in June 2010 to form one company, creating the industry's largest network of clients on one product platform, resulting in a single patient record.[16]

Allscripts is set to pay nearly $9.75 million to the proposed class to settle claims of securities fraud, after the company allegedly overstated its ability to integrate its Microsoft.NET and SQL Server with those of Eclipsys following their $1.3 billion merger.[17]

References

  1. "Analytics and Insights at Allscripts".
  2. "Care Coordination at Allscripts".
  3. "Clinical Products at Allscripts".
  4. "Financial Products at Allscripts".
  5. "Patient Engagement at Allscripts".
  6. 1 2 3 4 5 6 https://finance.yahoo.com/quote/MDRX/financials?p=MDRX
  7. "About Us". Allscripts. 2015-02-08.
  8. "Allscripts announces strategic acquisitions of dbMotion and Jardogs".
  9. "Allscripts MyWay EHR Transitions To Professional Suite". www.mdbuyline.com. Retrieved 2016-05-02.
  10. "Allscripts to Discontinue MyWay EHR". EMR Thoughts. 2012-10-05. Retrieved 2016-05-02.
  11. http://www.medscape.com/viewarticle/779721
  12. EHRIntelligence. "Allscripts Guilty of Deception in EHR Certification, Sales Fight". EHRIntelligence. Retrieved 2016-05-02.
  13. "Allscripts Lawsuit Serves As Warning To Physicians". www.healthitoutcomes.com. Retrieved 2016-05-02.
  14. "Allscripts, Eclipsys to Merge in $1.3 billion deal". www.healthcareitnews.com. Retrieved 2016-05-02.
  15. "How Allscripts ended up with an $9.75M class action settlement". Healthcare Dive. Retrieved 2016-05-02.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.